openPR Logo
Press release

P2X7 Receptor Antagonists Market Top Companies in Market Like GlaxoSmithKline, Johnson & Johnson, AstraZeneca, RaQualia Pharma, Evotec

07-01-2019 12:51 PM CET | Health & Medicine

Press release from: Coherent Market Insights

P2X7 Receptor Antagonists

P2X7 Receptor Antagonists

Manufacturers such as GlaxoSmithKline Plc, Johnson and Johnson, AstraZeneca plc, Asahi Kasei Corporation, and others have potential molecules in the pipeline.

Asahi Kasei Corporation, AstraZeneca Plc, and RaQualia Pharma Inc. have their products in preclinical stages for various indications such as analgesics, inflammation, and other indications.

GlaxoSmithKline Plc, Johnson & Johnson, and Evotec AG have these molecule for indications such as pain conditions, inflammatory conditions, major depressive disorder, and mood disorders.

Although, these molecules are in early stages of development, and faster clinical trials and active interest by companies such as Evotec AG, and Asahi Kasei Pharma to advance the pipeline is expected to support growth of the global P2X7 receptor antagonists market over the forecast period.

The P2X7 receptor is an ATP-gated, non-selective cation channel that has been linked to a number of inflammatory diseases. Activation of the P2X7 receptor by elevated levels of adenosine triphosphate (ATP) results in the release of pro-inflammatory cytokines and elevated levels of these cytokines has been associated with a variety of disease states. So, P2X7 receptor antagonists can be viable therapeutic agents, which is why leading manufacturers such as GlaxoSmithKline Plc., Johnson & Johnson, AstraZeneca Plc., and other manufacturers such as RaQualia Pharma, Evotec AG, and Asahi Kasei Corporation are working towards development of P2X7 receptor antagonist. Currently, there is no P2X7 receptor antagonist available in the market, and not a single P2X7 receptor antagonist in late stages of clinical trials. Therefore, manufacturers are competing on the same level with respect to the P2X7 receptor antagonist development. The category has a lucrative opportunity if a drug is introduced into the market, provided a drug successfully completes clinical trials. First mover to complete clinical trials, (and first to launch) will be able to gain significant share in the market, as healthcare systems always demand new medicines. Currently, opioid medications are heavily used for pain management and are highly addictive. Therefore, approval and launch of a non-addictive pain management option is expected to be a breakthrough in this product space.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/2595

Potential of P2X7 receptor antagonists in treatment of various diseases is expected to drive the global P2X7 receptor antagonist market growth over the forecast period

Various research studies reported activation of P2X7 channels due to release of pro-inflammatory cytokines IL-1b and IL-18. As adenosine triphosphate (ATP) has lowest affinity for P2X7 among all other purinergic ion channels (P2X4, P2X3, and others), extracellular ATP rarely activates P2X7 channel. P2X7 receptor antagonists have significant therapeutic potential, as P2X7 receptors have been found to be associated with regulation of inflammation, and all immune cell types (lymphocytes, macrophages, monocytes, and others) express P2X7R. Moreover, P2X7 ion channel has been directly linked to major depression and animal studies have shown that antagonism of P2X7 with centrally penetrant antagonists resulted in antidepressant-like behavior in animal models. Therefore, inflammation, pain indications, mood disorders, and depression are the potential areas among others where, P2X7 is involved, and its antagonism can modify disease outcomes, or can be a disease-modifying therapy. As such, P2X7 is an ideal drug target as antagonism of P2X7 channel would not cause any serious side effects, as antagonism will only start when the channel is activated by high ATP concentrations, believed to happen during pathology of neuroinflammatory disorders of the Central Nervous System (CNS) such as stroke, epilepsy, multiple sclerosis, chronic neurodegenerative, and neuropsychiatric diseases. These factors are expected to support global P2X7 receptor antagonist market growth over the forecast period.

The global P2X7 receptor antagonist market size was US$ 96.6 million in 2024, and is expected to witness a robust CAGR of 18.3% over the forecast period (2024–2026).

P2X7 receptor antagonists are still in the developmental stage and will require regulatory approval for introduction into the market. Manufacturers need to file an Investigational New Drug Application (IND) with the U.S. Food & Drug Application (FDA). Every drug is required to go through the approval process set by the FDA. P2X7 antagonists will be going through all the clinical trials after filing an Investigational New Drug (IND) application as any other new drug. However, the pharmaceutical organizations face several challenges for introducing these medications in the market due to a stringent regulatory approval process. These factors are considered in global P2X7 receptor antagonist market and factors affecting global P2X7 receptor antagonist market growth.

Market Dynamics

P2X7 Receptor Antagonists drug category is highly lucrative, as no drug therapies are available in this category. Leading organizations are investing in research and development of drugs in this category, which is expected to help market players in generating high revenue using patent protection. Disease and conditions such as major depressive disorders, mood disorders, chronic pain, and inflammation are highly prevalent and their incidence is also increasing. According to National Health Service Digital (NHS Digital), U.K., antidepressants medications prescriptions observed the largest increase in 2016, indicating the prevalence of depressive disorders. If launched, P2X7 receptor antagonists will be capable of acquiring a significant amount of market share for the disease or indication for which they have been approved. Drug manufacturers are also advancing the P2X7 antagonist drug category by developing innovative drugs such as AKP-23494954/RQ-00466479 (Asahi Kasei/RaQualia Pharma). These factors are expected to support global P2X7 receptor antagonist market growth over the forecast period.

Get PDF Brochure of This Business Report:
https://www.coherentmarketinsights.com/insight/request-pdf/2595

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release P2X7 Receptor Antagonists Market Top Companies in Market Like GlaxoSmithKline, Johnson & Johnson, AstraZeneca, RaQualia Pharma, Evotec here

News-ID: 1792629 • Views:

More Releases from Coherent Market Insights

High End Greenhouse Market Exploration 2024 to 2031: Innovations, Key Players Data and Upcoming Opportunities |Texas Greenhouse Company Inc., Nexus Corporation
High End Greenhouse Market Exploration 2024 to 2031: Innovations, Key Players Da …
The global high end greenhouse market is estimated to surpass US$ 3,025.1 million by the end of 2030 in terms of revenue, exhibiting a CAGR of 5.2% during the forecast period (2023 to 2030). New Research Study High End Greenhouse Market 2024 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook has been added to Coherent Market insight The High End Greenhouse Market research
Tattoo Accessories Market Insights Discussed Regarding Size, Share & Growth Opportunity | Major companies operating in the global tattoo accessories market are: Cheyenne
Tattoo Accessories Market Insights Discussed Regarding Size, Share & Growth Oppo …
New Research Study Tattoo Accessories Market 2024 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook has been added to Coherent Market insight The Tattoo Accessories Market research report provides an analysis of major manufacturers, and geographic regions, and provides advanced information about the major challenges that will affect market growth. The report includes definition, classification, application and industrial chain structure, development trend, analysis
Adhesive Films Market Size and Share 2024-2031 Detailed Analysis by Company Profiles and Market Development Status |BASF SE, 3M, Ashland Inc., H.B. Fuller Company
Adhesive Films Market Size and Share 2024-2031 Detailed Analysis by Company Prof …
Global adhesive films market is projected to reach around US$ 25.37 Bn by 2030, in terms of revenue, exhibiting a CAGR of 5.8% during the forecast period (2023-2030). New Research Study Adhesive Films Market 2024 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook has been added to Coherent Market insight The Adhesive Films Market research report provides an analysis of major manufacturers, and geographic
Safety Knives Market Demand Increasing and Industry Analysis in Upcoming Years by 2024-2031 |   Martor KG, Slice, Inc., The Safety Knife Company
Safety Knives Market Demand Increasing and Industry Analysis in Upcoming Years b …
New Research Study Safety Knives Market 2024 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook has been added to Coherent Market insight The Safety Knives Market research report provides an analysis of major manufacturers, and geographic regions, and provides advanced information about the major challenges that will affect market growth. The report includes definition, classification, application and industrial chain structure, development trend, analysis

All 5 Releases


More Releases for P2X7

Growth Drivers of P2X7 Receptor Antagonists Market 2022-2028 based on Key Player …
Global P2X7 Receptor Antagonists Market Research Report provides a key analysis of the market status of the P2X7 Receptor Antagonists with the best facts and figures, meaning, definition, SWOT analysis, expert opinions, and the latest developments across the globe. The report also calculates the market size, Sales, Price, Revenue, Gross Margin, Market Share, cost structure, and growth rate. The report considers the revenue generated from the sales of This Report
P2X7 Receptor Antagonists Market | Asahi Kasei Corporation, GlaxoSmithKline Plc, …
P2X7 Receptor Antagonists Market top level players are analyzed in report based on current and future development status, and P2X7 Receptor Antagonists market estimations from 2020 to 2027 in terms of revenue and volume. This report provides strategic recommendations consulted by the industrial experts including market share worldwide, future outlook, cost profit structure, supply, raw materials, labour cost, manufacturing expenses, latest market trends, demands, ROI. The P2X7 Receptor Antagonists market report
P2X7 Receptor Antagonists Market - Asahi Kasei Corporation, GlaxoSmithKline Plc, …
P2X7 Receptor Antagonists Market Report 2020 added recently by CMI, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a precise summary that illustrates the competitive milieu, growth opportunities and application landscape of the P2X7 Receptor Antagonists depending on the industry's financial and non-financial impact. The complete range of information related to the Global P2X7 Receptor Antagonists Market is obtained
P2X7 Receptor Antagonists Market Detailed Analysis of Current Industry Figures W …
Complete study of the global P2X7 Receptor Antagonists market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global P2X7 Receptor Antagonists industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They
P2X7 Receptor Antagonists Market Growth And Major Players Asahi Kasei Corporatio …
P2X7 Receptor Antagonists Market Report 2020-2026 includes a comprehensive analysis of the present Market. The report starts with the basic P2X7 Receptor Antagonists industry overview and then goes into each and every detail. P2X7 Receptor Antagonists Market Report contains in depth information major manufacturers, opportunities, challenges, and industry trends and their impact on the market forecast. P2X7 Receptor Antagonists also provides data about the company and its operations. This report also
P2X7 Receptor Antagonists Market to 2025 | GlaxoSmithKline, AstraZeneca, Janssen …
This research report titled Global P2X7 Receptor Antagonists Market Size, Status and Forecast 2019-2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the P2X7 Receptor Antagonists Market during the period between 2019 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities